We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

19 hedge funds and large institutions have $334K invested in Stealth BioTherapeutics Corp. ADS in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

46% more funds holding

Funds holding: 13 → 19 (+6)

48% less capital invested

Capital invested by funds: $638K → $334K (-$304K)

Holders
19
Holders Change
+6
Holders Change %
+46.15%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$48.6K
2
VF
Virtu Financial
New York
+$34.5K
3
HighTower Advisors
HighTower Advisors
Illinois
+$19.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$18.6K
5
HF
HRT Financial
New York
+$12.5K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$11K
2
Citigroup
Citigroup
New York
-$4K
3
Morgan Stanley
Morgan Stanley
New York
-$4K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$344
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$127K – – –
BBHC
2
Brown Brothers Harriman & Co
New York
$44K – – –
Citadel Advisors
3
Citadel Advisors
Florida
$36K +$48.6K +141,226 New
VF
4
Virtu Financial
New York
$25K +$34.5K +100,291 New
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$14K +$18.6K +54,174 New
HighTower Advisors
6
HighTower Advisors
Illinois
$14K +$19.3K +56,000 New
BFM
7
Boothbay Fund Management
New York
$12K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$12K – – –
Millennium Management
9
Millennium Management
New York
$10K +$1.02K +2,958 +8%
HF
10
HRT Financial
New York
$9K +$12.5K +36,342 New
UBS Group
11
UBS Group
Switzerland
$7K +$9.27K +26,940 +1,706%
Envestnet Asset Management
12
Envestnet Asset Management
Illinois
$5K +$1.25K +3,619 +25%
Renaissance Technologies
13
Renaissance Technologies
New York
$4K -$11K -32,008 -68%
Two Sigma Advisers
14
Two Sigma Advisers
New York
$4K -$344 -1,000 -6%
CAPTRUST Financial Advisors
15
CAPTRUST Financial Advisors
North Carolina
$4K +$5.16K +15,000 New
Two Sigma Investments
16
Two Sigma Investments
New York
$3K +$4.58K +13,314 New
Osaic Holdings
17
Osaic Holdings
Arizona
$2K +$1.07K +3,116 +48%
AA
18
AlphaMark Advisors
Kentucky
$1K – – –
UWM
19
Urban Wealth Management
California
$1K +$1.01K +2,939 New
Citigroup
20
Citigroup
New York
– -$4K -6,000 Closed
Morgan Stanley
21
Morgan Stanley
New York
– -$4K -5,000 Closed

MITO Hedge Fund Activity: Q2 2022 in Review

19 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q2 2022, worth a combined $334K — down 48% from $638K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new MITO positions and 2 closed out — a net gain of 6 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $48.6K. The largest seller was Renaissance Technologies, cutting an estimated $11K.

  • 19 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q2 2022, up from 13 in Q1 2022.
  • Funds reported $334K of Stealth BioTherapeutics Corp. ADS stock for Q2 2022, down 48% quarter-over-quarter.
  • 8 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q2 2022 and 2 closed out, a net change of +6 holders.
  • The largest Stealth BioTherapeutics Corp. ADS buyer in Q2 2022 was Citadel Advisors, an estimated $48.6K added.
  • The largest Stealth BioTherapeutics Corp. ADS seller in Q2 2022 was Renaissance Technologies, an estimated $11K sold.

Based on aggregated 13F filings for Q2 2022.